
0:00
16:32
In this week's episode, Nick and Geoff cover two timely benefits stories. First, EY announces a $100 million bonus pool for employees who demonstrate human skills, a notable signal from one of the world's largest consulting firms about what it still values in an AI-saturated environment. Then, a Business Group on Health survey reveals that 14% of US employers have dropped or plan to drop GLP-1 coverage from their 2027 benefits. Nick and Geoff debate where employer adoption goes from here.
Key Takeaways
- EY has allocated $100 million in bonuses for employees who demonstrate human or people skills, signaling that in a consulting business built on client relationships, AI cannot replace the value of human judgment and connection
- Geoff, a former EY employee, notes that consulting is a business where the partner selling the engagement, putting a narrative around data, and building long-term client trust is doing work that AI simply cannot replicate, making the $100 million commitment less surprising than it might appear
- Healthcare costs are rising well above general inflation, with health insurance costs up approximately 8.5% last year and projected to rise 9.2% for 2027, creating real budget pressure on employer benefits decisions
- A Business Group on Health survey found that 14% of US employers have or plan to drop GLP-1 coverage from their 2027 benefits, a meaningful difference considering 36% cover the drug for diabetes and weight loss (60% cover it for diabetes only)
- The key difference between enthusiastic GLP-1 adopters like Bank of America and the 14% walking away is likely not disagreement about the drug's efficacy but workforce profile—high-turnover employers bear the medication cost without capturing the long-term health benefits that justify it
More episodes from "Wellable Weekly"



Don't miss an episode of “Wellable Weekly” and subscribe to it in the GetPodcast app.








